PAI-1 and α2-antiplasmin are frequently upregulated in systemic and organ-specific conditions—including RA, SLE, SSc, T1D, and GD—consistent with hypofibrinolysis and fibrin persistence. Here, SERPINE1 is linked to type 1 diabetes mellitus.